Monitoring Asthma de Peter G. Gibson

Monitoring Asthma

Peter G. Gibson

en Limba Engleză Paperback – 19 iun 2019

Providing a solid foundation for specialists in asthma treatment and control, this guide illustrates the importance of asthma monitoring practices for up-to-date assessments of disease levels in specific population groups; the identification of social, geographical, and environmental factors that may influence the development of asthma; and the design of improved and cost-effective prevention and management strategies for optimal patient care.

Citește tot Restrânge

Toate formatele și edițiile

	Preț	Express
Paperback (1)	357^.29 lei 6-8 săpt.
CRC Press – 19 iun 2019	357^.29 lei 6-8 săpt.
Hardback (1)	987^.51 lei 6-8 săpt.
CRC Press – 12 aug 2005	987^.51 lei 6-8 săpt.

Cuprins

Symptoms: Monitoring and Perception. Quality of Life. Cough. Electronic Monitoring of PEF/Spirometry Technical Aspects and Clinical Results. Asthma and Telemedicine. Quality Control Analysis/Statistical Methods. Triggers: Allergen. Triggers: Occupational Exposures. Airway Hyperresponsiveness: Pharmacological Stimuli. Airway Hyperresponsiveness: Indirect Stimuli, Exercise, Mannitor, and Hypertonic Saline. Induced Sputum. Exhaled Gases. Monitoring Childhood Asthma. Asthma Epidemics, Monitoring Mortality. Monitoring Asthma in Populations. Role of Pharmacists in Asthma Monitoring. Post Marketing Drug Surveilance in Asthma

Descriere

Illustrating the importance of asthma monitoring practices, this book covers how to assess disease levels in specific population groups; identifies social, geographical, and environmental factors that may influence the development of asthma; and discusses the design of cost-effective prevention and management strategies. The book reviews monitoring devices and their interpretation using established and innovative statistical techniques, methods of self-monitoring and monitoring using the Internet, monitoring strategies for the investigation of asthma triggers, and important findings gleaned from the post-marketing surveillance of asthma drugs and the monitoring of asthma mortality.